Table 2.

Clinical, biochemical, and serological characteristics of PBC patients

	PBC patients	Healthy controls
	(n = 30)	(n = 30)
Mean age (years, range)	64 (44–87)	60 (42–79)
Females (n, %)	30 (100 %)	30 (100 %)
AMA positivity (n, %)	28 (93 %)	n.a.
Liver cirrhosis (n, %)	4 (13 %)	n.a.
Total bilirubin (mg/dl) (n.v. <1.0)	0.64 ± 0.39	0.73 ± 0.18
Alkaline phosphatase (IU/l) (n.v. <279)	152.3 ± 207.3	168 ± 24
Alanine aminotransferase (U/l) (n.v. <50)	33 ± 26	32 ± 9
Albumin (g/dl) (n.v. >3.5)	4.33 ± 0.86	4.68 ± 0.03
Length of follow-up (months, range)	34 (14–56)	n.a.
Therapy with UDCA (n, %)	28 (93 %)	n.a.
Liver biopsy (n, %)	21 (72 %)	n.a.

Mean values ± standard deviation unless otherwise stated

n.a. not applicable, n.v. normal value